<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Coronary artery bypass graft surgery in patients with acute ST-elevation myocardial infarction</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Coronary artery bypass graft surgery in patients with acute ST-elevation myocardial infarction</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Coronary artery bypass graft surgery in patients with acute ST-elevation myocardial infarction</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John A Bittl, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gabriel S Aldea, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Donald Cutlip, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Todd F Dardas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 06, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>In patients with acute ST-elevation myocardial infarction (STEMI), prompt restoration of myocardial blood flow is essential to optimize myocardial salvage and decrease mortality. This is particularly important in the first few hours after symptom onset, when the amount of myocardium salvageable by reperfusion is greatest. Coronary artery reperfusion, if performed in a timely manner, improves clinical outcomes compared to no reperfusion in nearly all groups of patients with an acute STEMI. (See  <a class="medical medical_review" href="/z/d/html/72.html" rel="external">"Primary percutaneous coronary intervention in acute ST elevation myocardial infarction: Determinants of outcome", section on 'Time from hospital arrival (door-to-balloon time)'</a> and  <a class="medical medical_review" href="/z/d/html/55.html" rel="external">"Acute ST-elevation myocardial infarction: The use of fibrinolytic therapy", section on 'Timing'</a>.)</p><p>Both primary percutaneous coronary intervention and fibrinolysis can restore blood flow in an acutely occluded coronary artery in a much shorter time in most hospital settings than can coronary artery bypass graft surgery (CABG) and these procedures are preferred to CABG in most cases. (See  <a class="medical medical_review" href="/z/d/html/80.html" rel="external">"Acute ST-elevation myocardial infarction: Selecting a reperfusion strategy"</a>.)</p><p>This topic will address the indications, optimal timing, technical considerations, and outcomes of urgent or emergent CABG in patients with acute STEMI. The role of CABG in patients with non-ST elevation MI or unstable angina is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/46.html" rel="external">"Non-ST-elevation acute coronary syndromes: Selecting an approach to revascularization"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">INDICATIONS</span><span class="headingEndMark"> — </span>In all studies of percutaneous coronary intervention (PCI) or fibrinolysis, outcomes improve as the time from symptom onset to reperfusion decreases. (See  <a class="medical medical_review" href="/z/d/html/72.html" rel="external">"Primary percutaneous coronary intervention in acute ST elevation myocardial infarction: Determinants of outcome", section on 'Time from hospital arrival (door-to-balloon time)'</a> and  <a class="medical medical_review" href="/z/d/html/55.html" rel="external">"Acute ST-elevation myocardial infarction: The use of fibrinolytic therapy", section on 'Timing'</a>.)</p><p>In most cases, PCI or fibrinolysis can usually restore flow to the ischemic myocardium more quickly than coronary artery bypass graft surgery (CABG), largely attributable to delays in getting the patient to the operating room and the time it takes to complete the bypass surgical procedure. Thus, CABG is uncommonly used as the reperfusion strategy of choice in ST elevation myocardial infarction (STEMI); it is estimated that CABG is performed in 5 percent or less of cases [<a href="#rid1">1-3</a>]. In one study of 3,347,470 patients hospitalized for STEMI between 2002 and 2016, 7.7 percent underwent isolated CABG. The incidence of CABG after STEMI decreased over the study period from 9.2 percent in 2002 to 5.5 percent in 2016 [<a href="#rid4">4</a>]. </p><p>CABG may be considered for the several subgroups of patients with STEMI detailed below. </p><p class="headingAnchor" id="H5"><span class="h2">After unsuccessful or complicated percutaneous coronary intervention</span><span class="headingEndMark"> — </span>In most acute STEMI cases, the site of occlusion responsible for the MI can be identified and successfully opened with PCI and stenting. When successful, this leads to an improvement in clinical and electrocardiographic signs of ischemia. In a minority of cases, either the culprit lesion cannot be identified or reperfusion cannot be reestablished. In patients with STEMI and multivessel coronary artery disease, ongoing ischemia may be an indication for urgent/emergent CABG in an effort to minimize myocardial damage and decrease in-hospital morbidity and mortality. </p><p>Increased interventional experience and advances in technology have led to a decline in the incidence of acute complications of PCI in the setting of STEMI to about 1 percent [<a href="#rid5">5</a>]. Examples of complications for which urgent CABG might be indicated include failed stent deployment, extensive coronary artery dissection, perforation of a coronary artery leading to pericardial tamponade, or recurrent acute closure. (See  <a class="medical medical_review" href="/z/d/html/1562.html" rel="external">"Periprocedural complications of percutaneous coronary intervention", section on 'Emergency CABG for failed PCI'</a>.)</p><p>Patients with either unsuccessful or complicated PCI who have ongoing ischemia and anatomy suitable for CABG should be referred for consideration of CABG as opposed to a strategy of medical therapy only. The rationale includes older studies demonstrating acceptable surgical mortality after CABG in patients with failed balloon angioplasty [<a href="#rid6">6-9</a>]. Moreover, in patients with STEMI complicated by cardiogenic shock, an early revascularization strategy is associated with a significant survival benefit [<a href="#rid10">10</a>]. Evidence from all studies of patients who are reperfused with either fibrinolytic therapy or primary PCI shows outcomes are uniformly better than with medical therapy alone. (See  <a class="medical medical_review" href="/z/d/html/72.html" rel="external">"Primary percutaneous coronary intervention in acute ST elevation myocardial infarction: Determinants of outcome", section on 'Time from hospital arrival (door-to-balloon time)'</a> and  <a class="medical medical_review" href="/z/d/html/55.html" rel="external">"Acute ST-elevation myocardial infarction: The use of fibrinolytic therapy", section on 'Timing'</a>.)</p><p>The risks and benefits should be discussed among members of the heart team, including the patient and family. Factors favoring emergent CABG include a large amount of ischemic myocardium, good general health, bypassable vessels, and the ability to perform surgery within six hours of the PCI. The presence of life-threatening ventricular arrhythmia should also drive the decision for emergent CABG. Factors against performing emergent CABG include absence of ischemia, presence of a small area of myocardium at risk, poor surgical target(s), and a no-reflow state. (See <a class="local">'Life-threatening ventricular arrhythmias'</a> below.)</p><p class="headingAnchor" id="H7"><span class="h2">Mechanical complications of acute MI</span><span class="headingEndMark"> — </span>Mechanical complications of acute MI include rupture of the left ventricular free wall or interventricular septum and acute mitral regurgitation. Medical treatment alone results in close to 100 percent mortality in these patients [<a href="#rid11">11</a>]. Most of these patients will require emergency cardiac surgical repair of the mechanical defect; CABG will be performed at that time. The approach to these patients is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/63.html" rel="external">"Acute myocardial infarction: Mechanical complications"</a>.)</p><p>We prefer immediate CABG as opposed to PCI of the infarct related artery followed by CABG and repair of the mechanical defect since termination of the ischemia often does not lessen the adverse hemodynamic impact of the mechanical defect, which may cause death. However, in some patients, it may be appropriate to initially perform PCI and then have the patient undergo cardiac surgery. For example, a patient with an acutely occluded (culprit) lesion in the circumflex coronary artery, significant mitral regurgitation, and severe disease in the left anterior descending and right coronary arteries (LAD and RCA) might benefit from acute PCI of the circumflex and then CABG to the LAD and RCA with repair of the mitral valve. In this scenario, however, initial stent placement introduces the dilemma of performing CABG in a patient treated with dual antiplatelet therapy or delaying definitive surgery. </p><p>In all cases in which a mechanical defect has been identified, we recommend immediate consultation between the interventional cardiologist, the cardiothoracic surgeon, and other members of the multidisciplinary heart team.</p><p class="headingAnchor" id="H8"><span class="h2">As the primary reperfusion strategy</span><span class="headingEndMark"> — </span>Most patients with acute STEMI should receive either PCI or fibrinolysis as the primary reperfusion strategy. (See <a class="local">'Indications'</a> above.) Studies of patients treated with either fibrinolysis or PCI have demonstrated that outcomes improve as the time to reperfusion decreases. </p><p>Approximately 50 percent of patients with STEMI have multivessel disease [<a href="#rid12">12</a>]. In stable patients with left main or severe three vessel coronary artery disease, CABG is often preferred to PCI  (<a class="graphic graphic_table graphicRef61364" href="/z/d/graphic/61364.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/z/d/html/1579.html" rel="external">"Revascularization in patients with stable coronary artery disease: Coronary artery bypass graft surgery versus percutaneous coronary intervention", section on 'Summary and recommendations'</a> and  <a class="medical medical_review" href="/z/d/html/1555.html" rel="external">"Left main coronary artery disease", section on 'Summary and recommendations'</a>.)</p><p>There are no randomized trials or large, well-conducted observational studies that have compared PCI to CABG in patients with left main or severe multivessel disease in the setting of an acute MI. Our experience is that PCI can be performed successfully and without major complication in the majority of cases. The decision of whether to perform PCI or CABG as the primary reperfusion strategy in patients with left main coronary artery disease or severe multivessel disease who are unstable or who have ongoing ischemia is complex and should be individualized. Management should involve cardiothoracic surgeons and interventional cardiologists on the multidisciplinary heart team. The discussion should include deciding on the primary reperfusion strategy and subsequent steps after "culprit lesion" intervention if PCI is performed, as well as what will be done if initial catheter based therapy fails. The role of non-culprit PCI in STEMI patients is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/103273.html" rel="external">"Acute coronary syndromes: Approach to nonculprit lesions", section on 'STEMI'</a>.)</p><p>We believe it is reasonable to perform PCI of a culprit unprotected left main coronary artery if distal flow is abnormal and PCI can be performed more rapidly and safely than CABG. This recommendation is consistent with that made in the 2021 American College of Cardiology Foundation/American Heart Association/Society of Cardiovascular angiography and Intervention (ACC/AHA/SCAI) revascularization guideline [<a href="#rid13">13-15</a>] and the 2018 European Society of Cardiology/European Association of Cardiothoracic Surgery Guidelines on Myocardial Revascularization [<a href="#rid16">16</a>].</p><p>Patients who might benefit from CABG as the primary reperfusion strategy include those who are no longer showing signs of acute ischemia (patients who have stabilized) and have coronary anatomy at the time of coronary angiography that suggests a benefit from CABG as opposed to PCI. Patients with left main or severe multivessel coronary disease, particularly with depressed left ventricular systolic function or those with diabetes are examples. If the patient is stable without signs or symptoms of ongoing ischemia either clinically or by electrocardiogram, CABG should be strongly considered as the primary reperfusion strategy in these patients. (See  <a class="medical medical_review" href="/z/d/html/1579.html" rel="external">"Revascularization in patients with stable coronary artery disease: Coronary artery bypass graft surgery versus percutaneous coronary intervention", section on 'Summary and recommendations'</a>.)</p><p class="headingAnchor" id="H259318985"><span class="h2">Late presentation or recurrent ischemia</span><span class="headingEndMark"> — </span>Some patients with STEMI present late (after 12 hours) and have no evidence of ongoing ischemia at the time of presentation; thus, urgent intervention is not necessary. Subsequently, some of these individuals develop recurrent or inducible angina or have reinfarction and require revascularization with either PCI or CABG. We suggest using recommendations made for patients with stable coronary artery disease as a guide for who should be referred for CABG and who for PCI. (See  <a class="medical medical_review" href="/z/d/html/1579.html" rel="external">"Revascularization in patients with stable coronary artery disease: Coronary artery bypass graft surgery versus percutaneous coronary intervention", section on 'Summary and recommendations'</a>.) </p><p>A few patients with STEMI who have received successful primary PCI develop recurrent angina due to ischemia in a territory not reperfused at the time of PCI. Many of these patients should be referred for repeat revascularization with either PCI or CABG. For patients with multivessel disease who fall into this category within the first 48 hours after STEMI, we agree with the 2021 ACC/AHA/SCAI coronary revascularization guideline and the 2018 European Society of Cardiology/European Association of Cardiothoracic Surgery Guidelines on Myocardial Revascularization [<a href="#rid15">15,16</a>] that state that complete revascularization by either multivessel PCI or urgent CABG is reasonable and in selected patients might be the preferred approach compared with a delayed revascularization strategy [<a href="#rid17">17</a>]. </p><p class="headingAnchor" id="H2860987"><span class="h2">Cardiogenic shock</span><span class="headingEndMark"> — </span>Cardiogenic shock occurs in 6 to 7 percent of patients with acute MI (excluding patients with mechanical complications). This complication signifies loss of at least 40 percent of the left ventricular contractile mass. Mortality with medical treatment of cardiogenic shock in acute MI approaches 80 percent. (See  <a class="medical medical_review" href="/z/d/html/44.html" rel="external">"Clinical manifestations and diagnosis of cardiogenic shock in acute myocardial infarction"</a>.)</p><p>Cardiogenic shock occurs most often in patients with left main or severe three vessel coronary artery disease, but can occur in patients with one- or two-vessel disease. Although the limited evidence suggests similar outcomes, we prefer PCI to CABG, irrespective of the extent of disease, if it can be performed in a timely manner by a skilled team and if a mechanical complication of STEMI is not present. In the SHOCK trial, patients with STEMI and cardiogenic shock were randomized to either initial medical stabilization or to early revascularization. In the group assigned revascularization, 37.5 percent underwent CABG [<a href="#rid1">1</a>]. The secondary outcome of survival at six months was significantly higher in the group of patients randomized to early revascularization and treated with either PCI or CABG [<a href="#rid10">10</a>]. The full discussion of the use of CABG in such patients is presented separately. (See  <a class="medical medical_review" href="/z/d/html/83.html" rel="external">"Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction"</a>.)</p><p class="headingAnchor" id="H2860937"><span class="h2">After failed fibrinolysis</span><span class="headingEndMark"> — </span>CABG is employed infrequently for revascularization after failed fibrinolysis. PCI is preferred in this setting because of increased risks of perioperative mortality and major hemorrhage with CABG, especially if the interval between administration of the fibrinolytic agent and surgery is short. In an analysis from the TIMI II study, 390 patients underwent CABG after fibrinolytic treatment [<a href="#rid18">18</a>]. Patients undergoing surgery within 24 hours of study, compared to those undergoing later surgery, had higher rates of perioperative mortality (17 versus 4 percent) and major hemorrhage (74 versus 51 percent). (See  <a class="medical medical_review" href="/z/d/html/91.html" rel="external">"Diagnosis and management of failed fibrinolysis or threatened reocclusion in acute ST-elevation myocardial infarction"</a>.)</p><p class="headingAnchor" id="H358599859"><span class="h2">Life-threatening ventricular arrhythmias</span><span class="headingEndMark"> — </span>Life-threatening ventricular arrhythmias occurring in the setting of acute MI are triggered by ischemic myocardium or the combination of ischemic myocardium plus scar formed from prior events. They are associated with worse in-hospital mortality. (See  <a class="medical medical_review" href="/z/d/html/1060.html" rel="external">"Ventricular arrhythmias during acute myocardial infarction: Incidence, mechanisms, and clinical features"</a>.)</p><p>There are no randomized trials or important observational studies that evaluated the optimal management strategy in these patients. Small series have included patients with life-threatening ventricular arrhythmia in the setting of acute MI [<a href="#rid19">19,20</a>]. These studies suggest that operative and long-term mortality (approximately 7 and 15 percent, respectively) are reasonable with urgent CABG and that the incidence of sudden death is reduced compared to no CABG.</p><p>As life-threatening ventricular arrhythmias often represent ongoing ischemia in the setting of STEMI, our approach to revascularization is similar to the broad population of patients with STEMI for whom we prefer PCI to CABG. We agree with recommendations made in the 2011 American College of Cardiology Foundation/American Heart Association CABG guideline and the 2018 European Society of Cardiology/European Association of Cardiothoracic Surgery Guidelines on Myocardial Revascularization, which state that urgent CABG is a reasonable approach for patients with ongoing ischemia who will not undergo emergent revascularization with PCI and who have left main stenosis greater than or equal to 50 percent and/or three-vessel coronary artery disease [<a href="#rid16">16,17</a>]. </p><p class="headingAnchor" id="H9"><span class="h1">TIMING</span><span class="headingEndMark"> — </span>For those patients in whom coronary artery bypass graft surgery (CABG) will be performed, the optimal timing depends on the indication. Ongoing ischemia, cardiogenic shock, percutaneous coronary intervention failure, and mechanical complications are indications for emergency operation.</p><p>The optimal timing in more stable patients with indications for CABG is unclear, with some older studies showing increased mortality when CABG was performed in the first 12 to 24 hours after acute myocardial infarction (MI) [<a href="#rid18">18,21-25</a>] and others not [<a href="#rid26">26-31</a>].</p><p>We feel that CABG can be performed safely in patients with post-MI angina based upon the patient's clinical status. In our view, patients presenting within six hours after onset of symptoms should be operated emergently to maximize myocardial salvage. The goal should be to complete bypass within 12 hours of symptom onset. </p><p>Patients who present later than six hours after onset of symptoms when myocardial necrosis has reached its peak should probably be delayed for three to four days to decrease mortality and morbidity, including bleeding complications [<a href="#rid1">1,32</a>]. More recent data showed that CABG performed within the first 48 hours after STEMI is associated with increased mortality and morbidity [<a href="#rid4">4</a>]. Thus, for those who lack the indication for emergency operation, CABG should be deferred to day 3 or later after STEMI. </p><p>For patients with recurrent or inducible ischemia or reinfarction, particularly those with multivessel disease, CABG within 48 hours is a reasonable strategy compared to more delayed revascularization.</p><p class="headingAnchor" id="H10"><span class="h1">TECHNICAL CONSIDERATIONS</span><span class="headingEndMark"> — </span>Several technical issues need to be considered in patients undergoing coronary artery bypass graft surgery (CABG) after acute ST elevation myocardial infarction (STEMI).</p><p class="headingAnchor" id="H11"><span class="h2">Minimizing ischemic time</span><span class="headingEndMark"> — </span>An expeditious operation to shorten the interval during which the patient is actively ischemic or hemodynamically unstable is a critical component of the overall strategy aimed at reducing myocardial injury and systemic organ dysfunction. Thus, patients who are continuously ischemic, hemodynamically unstable, or having recurrent life-threatening arrhythmias should be stabilized and transferred rapidly to the operating room. Resuscitation should continue en-route to surgery, and unnecessary delays should be avoided. Aggressive use of pharmacologic agents and the intraaortic balloon pump (IABP) is essential to achieve stabilization. Percutaneous bypass may be used in some patients as part of resuscitation in the catheterization laboratory. (See  <a class="medical medical_review" href="/z/d/html/1492.html" rel="external">"Short-term mechanical circulatory assist devices"</a>.)</p><p class="headingAnchor" id="H12"><span class="h2">Intraaortic balloon pump</span><span class="headingEndMark"> — </span>The IABP can be an extremely important adjunct to surgical treatment in patients with acute MI and mechanical complications. In a propensity-matched study of 400 patients who underwent CABG after acute STEMI or NSTEMI, preoperative insertion of IABP was associated with reduced in-hospital mortality and myocardial injury [<a href="#rid33">33</a>]. For other patients, such as those with cardiogenic shock, the role of a preoperative IABP is less clear. (See  <a class="medical medical_review" href="/z/d/html/83.html" rel="external">"Prognosis and treatment of cardiogenic shock complicating acute myocardial infarction", section on 'Summary and Recommendations'</a> and  <a class="medical medical_review" href="/z/d/html/1482.html" rel="external">"Intraaortic balloon pump counterpulsation"</a>.)</p><p class="headingAnchor" id="H1489981804"><span class="h2">Micro-axial flow pump (Impella)</span><span class="headingEndMark"> — </span>It is uncertain if an Impella device is helpful for hemodynamic support during CABG in patients with an acute STEMI. An Impella flow pump is a left ventricular assist device that is inserted through the aortic valve on a pigtail catheter (Impella, Abiomed, Danvers, MA). It has received some attention in the setting of supported PCI [<a href="#rid34">34</a>]. However, there is only anecdotal experience with its use for high-risk CABG [<a href="#rid35">35</a>]. It may worsen right-to-left shunting in the setting of a ventricular septal defect [<a href="#rid36">36</a>].</p><p class="headingAnchor" id="H3664948061"><span class="h2">Extracorporeal membrane oxygenation (ECMO)</span><span class="headingEndMark"> — </span>Preoperative or postcardiopulmonary-bypass ECMO support should be considered in patients referred for emergency CABG and who remain in deep cardiogenic shock despite intense pharmacologic treatment and insertion of IABP. Optimal timing of initiation of ECMO is key to avoid irreversible shock and reduce mortality [<a href="#rid37">37</a>]. Contemporary United States national data demonstrated that the use of mechanical circulatory support for patients undergoing CABG after STEMI has increased over time [<a href="#rid4">4</a>]. (See  <a class="medical medical_review" href="/z/d/html/1625.html" rel="external">"Extracorporeal life support in adults in the intensive care unit: Overview"</a> and  <a class="medical medical_review" href="/z/d/html/127006.html" rel="external">"Short-term left ventricular mechanical circulatory support: Use of echocardiography during initiation and management"</a>.)</p><p class="headingAnchor" id="H13"><span class="h2">Type of graft</span><span class="headingEndMark"> — </span>The choice of bypass conduit is dictated by the patient's condition.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stable patients </strong>– In the stable patient, arterial revascularization (particularly the left internal mammary artery to the left anterior descending coronary artery) should be used because of its superior short- and long-term clinical results. Even in urgent or emergency situations, aggressive use of arterial conduits should be pursued if the patient can be stabilized. (See  <a class="medical medical_review" href="/z/d/html/1554.html" rel="external">"Coronary artery bypass graft surgery: Graft choices", section on 'Two arterial grafts'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Unstable patients </strong>– In the unstable patient, venous conduits are preferred. This affords a more expeditious revascularization and an opportunity to directly deliver cardioplegia, to control reperfusion to the acutely ischemic area, and to avoid postoperative vasospasm in patients who are usually on varying amounts of vasopressors [<a href="#rid38">38,39</a>]. </p><p></p><p class="headingAnchor" id="H259318725"><span class="h2">Minimally invasive CABG</span><span class="headingEndMark"> — </span>We believe that both on- and off-pump CABG are acceptable techniques for patients with STEMI. For most patients who are referred for CABG, we recommend an on-pump as opposed to off-pump procedure.</p><p>An early report of 57 patients with acute MI treated with minimally invasive (off-pump) CABG without cardiopulmonary bypass suggested that this procedure is associated with relatively low risk [<a href="#rid40">40</a>]. In another trial, 128 patients within 48 hours of symptom onset were randomly assigned to either on- or off-pump CABG [<a href="#rid41">41</a>]. In-hospital mortality was significantly better in the off-pump group (1.6 versus 7.7 percent). (See  <a class="medical medical_review" href="/z/d/html/1558.html" rel="external">"Off-pump and minimally invasive direct coronary artery bypass graft surgery: Clinical use"</a>.)</p><p class="headingAnchor" id="H259318798"><span class="h2">Hybrid procedure</span><span class="headingEndMark"> — </span>An alternative approach to CABG in high-risk groups of patients with STEMI is a hybrid operation. A subset of patients with suitable anatomy may benefit from a minimally-invasive off-pump CABG of a left internal mammary to the left anterior descending coronary artery in conjunction with percutaneous coronary intervention to other significantly diseased coronary arteries. In select groups of patients, this can be achieved during the same procedure performed in a hybrid operating room. In other patients, the revascularization procedure can be staged. (See  <a class="medical medical_review" href="/z/d/html/1559.html" rel="external">"Minimally invasive coronary artery bypass graft surgery: Definitions and technical issues", section on 'Hybrid CABG-PCI procedures'</a>.)</p><p class="headingAnchor" id="H16"><span class="h1">OUTCOMES AFTER CABG</span><span class="headingEndMark"> — </span>Numerous observational studies published between the mid-1970s and the mid-1990s reported early and late outcomes after coronary artery bypass graft surgery for ST elevation myocardial infarction. Hospital mortality was less than 10 percent [<a href="#rid1">1,18,23-25,27-32,38,42-68</a>] and long-term freedom from angina and survival were improved compared to medical therapy [<a href="#rid18">18,24,25,27-29,38,44-48,50-58,60,62,65,66</a>]. Contemporary large-scale United States data indicate that despite an increase in patient comorbidities, the crude in-hospital mortality of CABG after STEMI did not significantly change over time (5.5 percent in 2002 versus 4.2 percent in 2016) [<a href="#rid4">4</a>].</p><p>However, the applicability of the results of these studies to patients treated since the introduction of percutaneous coronary intervention and the use of aggressive antithrombotic and statin therapy is limited. Observational studies that have evaluated in-hospital or 30-day mortality since 2000 have reported rates ranging between 1.7 and 22 percent [<a href="#rid1">1-3,69,70</a>]. The variation in mortality is likely explained by differences in patient selection and severity of illness. A Canadian national report summarized the outcomes of 341,001 episodes (323,862 patients) of acute MI between 2004 and 2013, of which 129,752 episodes were STEMI. Six thousand and seven hundred patients (5.2 percent) received CABG [<a href="#rid3">3</a>]. Operative mortality and readmission rates after emergency CABG in the setting of STEMI were 3 and 11 percent, respectively. There was a modest improvement in mortality and readmission rates during the early part of the study period, with some increase in the last two years [<a href="#rid3">3</a>].</p><p class="headingAnchor" id="H526663924"><span class="h1">RECOMMENDATIONS OF OTHERS</span><span class="headingEndMark"> — </span>Recommendations for the use of coronary artery bypass graft surgery in patients with ST-elevation myocardial infarction are available from the American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions [<a href="#rid3">3,15,17,71,72</a>]. Our recommendations are generally consistent with those made by these organizations.</p><p class="headingAnchor" id="H4070744096"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/113180.html" rel="external">"Society guideline links: ST-elevation myocardial infarction (STEMI)"</a>.)</p><p class="headingAnchor" id="H21"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, “The Basics” and “Beyond the Basics.” The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on “patient info” and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/z/d/html/3425.html" rel="external">"Patient education: Coronary artery bypass graft surgery (Beyond the Basics)"</a>) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/16430.html" rel="external">"Patient education: Coronary artery bypass graft surgery (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H22"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Background </strong>– Long-term outcome after ST-elevation myocardial infarction (STEMI) is largely determined by the speed with which blood flow is restored to the ischemic myocardium. Revascularization with primary percutaneous coronary intervention (PCI) or fibrinolysis and rescue PCI increase this speed more than coronary artery bypass graft surgery (CABG). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications </strong>– In patients with coronary anatomy suitable for surgery, the role of CABG after acute MI is limited to selected patients with the following (see <a class="local">'Indications'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cardiogenic shock</p><p class="bulletIndent2"><span class="glyph">•</span>Unsuccessful or complicated primary PCI</p><p class="bulletIndent2"><span class="glyph">•</span>Mechanical complications, </p><p class="bulletIndent2"><span class="glyph">•</span>A late presentation (after 12 hours)</p><p class="bulletIndent2"><span class="glyph">•</span>Early recurrent ischemia</p><p class="bulletIndent2"><span class="glyph">•</span>STEMI patients who are not candidates for fibrinolysis or primary PCI</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Timing </strong>– The optimal timing depends on the indication. Ongoing ischemia, cardiogenic shock, PCI failure, and mechanical complications are indications for emergency operation. The optimal timing in more stable patients with indications for CABG is unclear; the decision on timing should be made by a multidisciplinary team. (See <a class="local">'Timing'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We recommend the following uses for CABG (or PCI) in patients with acute STEMI:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For most patients, fibrinolysis or PCI is preferred to CABG. This preference for PCI includes patients with one- or two-vessel disease who have cardiogenic shock, but are without mechanical complications, as the restoration of myocardial blood flow with PCI of the infarct related artery may take only minutes after diagnostic coronary angiography has been performed. (See <a class="local">'Indications'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with left main (as the culprit lesion) or three vessel coronary artery disease, with or without cardiogenic shock, who do not have mechanical complications (such as acute mitral regurgitation or rupture of either the ventricular septal or free walls), we suggest immediate PCI rather than CABG (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). CABG is a reasonable alternative to PCI when it can be performed more rapidly than PCI. (See <a class="local">'Cardiogenic shock'</a> above and <a class="local">'As the primary reperfusion strategy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with unsuccessful or complicated PCI with evidence of ongoing ischemia and in whom the coronary anatomy is suitable for CABG, we recommend emergency CABG rather than medical therapy (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>). (See <a class="local">'Introduction'</a> above and <a class="local">'After unsuccessful or complicated percutaneous coronary intervention'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For most patients with hemodynamically significant mechanical complications, we recommended immediate CABG and attempt at repair of the mechanical defect rather than a strategy of PCI followed by cardiac surgery (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>). (See <a class="local">'Mechanical complications of acute MI'</a> above.)</p><p></p><p class="bulletIndent2">For some patients with ischemic mitral regurgitation, primary PCI with hemodynamic support may reasonably preferred to CABG. </p><p></p><p class="headingAnchor" id="H3796301310"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Oz Shapira, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Gu YL, van der Horst IC, Douglas YL, et al. Role of coronary artery bypass grafting during the acute and subacute phase of ST-elevation myocardial infarction. Neth Heart J 2010; 18:348.</a></li><li><a class="nounderline abstract_t">Stone GW, Brodie BR, Griffin JJ, et al. Role of cardiac surgery in the hospital phase management of patients treated with primary angioplasty for acute myocardial infarction. Am J Cardiol 2000; 85:1292.</a></li><li><a class="nounderline abstract_t">Tran DT, Welsh RC, Ohinmaa A, et al. Quality of Acute Myocardial Infarction Care in Canada: A 10-Year Review of 30-Day In-Hospital Mortality and 30-Day Hospital Readmission. Can J Cardiol 2017; 33:1319.</a></li><li><a class="nounderline abstract_t">Elbadawi A, Elzeneini M, Elgendy IY, et al. Coronary artery bypass grafting after acute ST-elevation myocardial infarction. J Thorac Cardiovasc Surg 2023; 165:672.</a></li><li><a class="nounderline abstract_t">Lee JM, Hwang D, Park J, et al. Percutaneous Coronary Intervention at Centers With and Without On-Site Surgical Backup: An Updated Meta-Analysis of 23 Studies. Circulation 2015; 132:388.</a></li><li><a class="nounderline abstract_t">Zapolanski A, Rosenblum J, Myler RK, et al. Emergency coronary artery bypass surgery following failed balloon angioplasty: role of the internal mammary artery graft. J Card Surg 1991; 6:439.</a></li><li><a class="nounderline abstract_t">Craver JM, Weintraub WS, Jones EL, et al. Emergency coronary artery bypass surgery for failed percutaneous coronary angioplasty. A 10-year experience. Ann Surg 1992; 215:425.</a></li><li><a class="nounderline abstract_t">Buffet P, Danchin N, Villemot JP, et al. Early and long-term outcome after emergency coronary artery bypass surgery after failed coronary angioplasty. Circulation 1991; 84:III254.</a></li><li><a class="nounderline abstract_t">Talley JD, Weintraub WS, Roubin GS, et al. Failed elective percutaneous transluminal coronary angioplasty requiring coronary artery bypass surgery. In-hospital and late clinical outcome at 5 years. Circulation 1990; 82:1203.</a></li><li><a class="nounderline abstract_t">Hochman JS, Lamas GA, Buller CE, et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 2006; 355:2395.</a></li><li><a class="nounderline abstract_t">Crenshaw BS, Granger CB, Birnbaum Y, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation 2000; 101:27.</a></li><li><a class="nounderline abstract_t">Toma M, Buller CE, Westerhout CM, et al. Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. Eur Heart J 2010; 31:1701.</a></li><li><a class="nounderline abstract_t">Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011; 124:e574.</a></li><li><a class="nounderline abstract_t">Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011; 124:2574.</a></li><li><a class="nounderline abstract_t">Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022; 145:e4.</a></li><li><a class="nounderline abstract_t">Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019; 40:87.</a></li><li><a class="nounderline abstract_t">Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124:2610.</a></li><li><a class="nounderline abstract_t">Gersh BJ, Chesebro JH, Braunwald E, et al. Coronary artery bypass graft surgery after thrombolytic therapy in the Thrombolysis in Myocardial Infarction Trial, Phase II (TIMI II). J Am Coll Cardiol 1995; 25:395.</a></li><li><a class="nounderline abstract_t">Ngaage DL, Cale AR, Cowen ME, et al. Early and late survival after surgical revascularization for ischemic ventricular fibrillation/tachycardia. Ann Thorac Surg 2008; 85:1278.</a></li><li><a class="nounderline abstract_t">Every NR, Fahrenbruch CE, Hallstrom AP, et al. Influence of coronary bypass surgery on subsequent outcome of patients resuscitated from out of hospital cardiac arrest. J Am Coll Cardiol 1992; 19:1435.</a></li><li><a class="nounderline abstract_t">Lee DC, Oz MC, Weinberg AD, et al. Optimal timing of revascularization: transmural versus nontransmural acute myocardial infarction. Ann Thorac Surg 2001; 71:1197.</a></li><li><a class="nounderline abstract_t">Kennedy JW, Ivey TD, Misbach G, et al. Coronary artery bypass graft surgery early after acute myocardial infarction. Circulation 1989; 79:I73.</a></li><li><a class="nounderline abstract_t">Creswell LL, Moulton MJ, Cox JL, Rosenbloom M. Revascularization after acute myocardial infarction. Ann Thorac Surg 1995; 60:19.</a></li><li><a class="nounderline abstract_t">Nunley DL, Grunkemeier GL, Teply JF, et al. Coronary bypass operation following acute complicated myocardial infarction. J Thorac Cardiovasc Surg 1983; 85:485.</a></li><li><a class="nounderline abstract_t">Kereiakes DJ, Topol EJ, George BS, et al. Favorable early and long-term prognosis following coronary bypass surgery therapy for myocardial infarction: results of a multicenter trial. TAMI Study Group. Am Heart J 1989; 118:199.</a></li><li><a class="nounderline abstract_t">Ryan TJ. Revascularization for acute myocardial infarction. Strategies in need of revision. Circulation 1990; 82:II110.</a></li><li><a class="nounderline abstract_t">Naunheim KS, Kesler KA, Kanter KR, et al. Coronary artery bypass for recent infarction. Predictors of mortality. Circulation 1988; 78:I122.</a></li><li><a class="nounderline abstract_t">Applebaum R, House R, Rademaker A, et al. Coronary artery bypass grafting within thirty days of acute myocardial infarction. Early and late results in 406 patients. J Thorac Cardiovasc Surg 1991; 102:745.</a></li><li><a class="nounderline abstract_t">Hochberg MS, Parsonnet V, Gielchinsky I, et al. Timing of coronary revascularization after acute myocardial infarction. Early and late results in patients revascularized within seven weeks. J Thorac Cardiovasc Surg 1984; 88:914.</a></li><li><a class="nounderline abstract_t">Sintek CF, Pfeffer TA, Khonsari S. Surgical revascularization after acute myocardial infarction. Does timing make a difference? J Thorac Cardiovasc Surg 1994; 107:1317.</a></li><li><a class="nounderline abstract_t">Lee JH, Murrell HK, Strony J, et al. Risk analysis of coronary bypass surgery after acute myocardial infarction. Surgery 1997; 122:675.</a></li><li><a class="nounderline abstract_t">Thielmann M, Neuhäuser M, Marr A, et al. Predictors and outcomes of coronary artery bypass grafting in ST elevation myocardial infarction. Ann Thorac Surg 2007; 84:17.</a></li><li><a class="nounderline abstract_t">Grieshaber P, Schneider T, Oster L, et al. Prophylactic intra-aortic balloon counterpulsation before surgical myocardial revascularization in patients with acute myocardial infarction. Perfusion 2018; 33:390.</a></li><li><a class="nounderline abstract_t">O'Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation 2012; 126:1717.</a></li><li><a class="nounderline abstract_t">Sabra MJ, Andrews WG, Crandall ML, Pirris JP. The postoperative use of Impella as a ventricular assist device in high-risk patients undergoing coronary artery bypass surgery: A case series and comparison. J Card Surg 2020; 35:113.</a></li><li><a class="nounderline abstract_t">Rihal CS, Naidu SS, Givertz MM, et al. 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention. J Am Coll Cardiol 2015; 65:e7.</a></li><li><a class="nounderline abstract_t">Hamiko M, Slottosch I, Scherner M, et al. Timely extracorporeal membrane oxygenation assist reduces mortality after bypass surgery in patients with acute myocardial infarction. J Card Surg 2019; 34:1243.</a></li><li><a class="nounderline abstract_t">Allen BS, Buckberg GD, Fontan FM, et al. Superiority of controlled surgical reperfusion versus percutaneous transluminal coronary angioplasty in acute coronary occlusion. J Thorac Cardiovasc Surg 1993; 105:864.</a></li><li class="breakAll">Rankin JS, Morris JJ. Utilization of autologous arterial grafts for coronary artery bypass. In: Surgery of the Chest, Sabiston DC, Spencer FC (Eds), WB Saunders, Philadelphia 1995. p.1909.</li><li><a class="nounderline abstract_t">Mohr R, Moshkovitch Y, Shapira I, et al. Coronary artery bypass without cardiopulmonary bypass for patients with acute myocardial infarction. J Thorac Cardiovasc Surg 1999; 118:50.</a></li><li><a class="nounderline abstract_t">Fattouch K, Guccione F, Dioguardi P, et al. Off-pump versus on-pump myocardial revascularization in patients with ST-segment elevation myocardial infarction: a randomized trial. J Thorac Cardiovasc Surg 2009; 137:650.</a></li><li><a class="nounderline abstract_t">Gott JP, Han DC. Surgical treatment of acute myocardial infarct: clinical considerations. Semin Thorac Cardiovasc Surg 1995; 7:198.</a></li><li><a class="nounderline abstract_t">Dresdale AR, Paone G. Surgical treatment of acute myocardial infarction. Henry Ford Hosp Med J 1991; 39:245.</a></li><li><a class="nounderline abstract_t">Berg R Jr, Kendall RW, Duvoisin GE, et al. Acute myocardial infarction: a surgical emergency. J Thorac Cardiovasc Surg 1975; 70:432.</a></li><li><a class="nounderline abstract_t">DeWood MA, Notske RN, Berg R Jr, et al. Medical and surgical management of early Q wave myocardial infarction. I. Effects of surgical reperfusion on survival, recurrent myocardial infarction, sudden death and functional class at 10 or more years of follow-up. J Am Coll Cardiol 1989; 14:65.</a></li><li><a class="nounderline abstract_t">Every NR, Maynard C, Cochran RP, et al. Characteristics, management, and outcome of patients with acute myocardial infarction treated with bypass surgery. Myocardial Infarction Triage and Intervention Investigators. Circulation 1996; 94:II81.</a></li><li><a class="nounderline abstract_t">Guyton RA, Arcidi JM Jr, Langford DA, et al. Emergency coronary bypass for cardiogenic shock. Circulation 1987; 76:V22.</a></li><li><a class="nounderline abstract_t">Allen BS, Rosenkranz E, Buckberg GD, et al. Studies on prolonged acute regional ischemia. VI. Myocardial infarction with left ventricular power failure: a medical/surgical emergency requiring urgent revascularization with maximal protection of remote muscle. J Thorac Cardiovasc Surg 1989; 98:691.</a></li><li><a class="nounderline abstract_t">Bolooki H. Myocardial revascularization after acute infarction. Am J Cardiol 1975; 36:395.</a></li><li><a class="nounderline abstract_t">DeWood MA, Spores J, Notske RN, et al. Medical and surgical management of myocardial infarction. Am J Cardiol 1979; 44:1356.</a></li><li><a class="nounderline abstract_t">Berg R Jr, Selinger SL, Leonard JJ, et al. Immediate coronary artery bypass for acute evolving myocardial infarction. J Thorac Cardiovasc Surg 1981; 81:493.</a></li><li><a class="nounderline abstract_t">Jones EL, Waites TF, Craver JM, et al. Coronary bypass for relief of persistent pain following acute myocardial infarction. Ann Thorac Surg 1981; 32:33.</a></li><li><a class="nounderline abstract_t">Berg R Jr, Selinger SL, Leonard JJ, et al. Acute evolving myocardial infarction. A surgical emergency. J Thorac Cardiovasc Surg 1984; 88:902.</a></li><li><a class="nounderline abstract_t">Singh AK, Rivera R, Cooper GN Jr, Karlson KE. Early myocardial revascularization for postinfarction angina: results and long-term follow-up. J Am Coll Cardiol 1985; 6:1121.</a></li><li><a class="nounderline abstract_t">Phillips SJ, Zeff RH, Skinner JR, et al. Reperfusion protocol and results in 738 patients with evolving myocardial infarction. Ann Thorac Surg 1986; 41:119.</a></li><li><a class="nounderline abstract_t">Jones RN, Pifarré R, Sullivan HJ, et al. Early myocardial revascularization for postinfarction angina. Ann Thorac Surg 1987; 44:159.</a></li><li><a class="nounderline abstract_t">Amsel BJ, Walter PJ, Van der Mast M, Vander Sande J. Immediate bypass surgery (0.5-3 h) for evolving myocardial infarction. Adv Cardiol 1988; 36:178.</a></li><li><a class="nounderline abstract_t">Collins JJ Jr, Cohn LH, Shemin RJ, DiSesa VJ. Surgical treatment of evolving and sustained myocardial infarction. Adv Cardiol 1988; 36:189.</a></li><li><a class="nounderline abstract_t">Flameng W, Sergeant P, Vanhaecke J, Suy R. Emergency aortocoronary bypass surgery: late effects on infarct size and ventricular function. Adv Cardiol 1988; 36:195.</a></li><li><a class="nounderline abstract_t">Kirklin JK, Shimazaki Y, Digerness SB, Kirklin JW. Emergent surgical revascularization following acute myocardial infarction. Experimental and clinical considerations. Adv Cardiol 1988; 36:202.</a></li><li><a class="nounderline abstract_t">Vidne BA. Emergency coronary artery reperfusion for acute evolving myocardial infarction. Adv Cardiol 1988; 36:219.</a></li><li><a class="nounderline abstract_t">Gardner TJ, Stuart RS, Greene PS, Baumgartner WA. The risk of coronary bypass surgery for patients with postinfarction angina. Circulation 1989; 79:I79.</a></li><li><a class="nounderline abstract_t">Kouchoukos NT, Murphy S, Philpott T, et al. Coronary artery bypass grafting for postinfarction angina pectoris. Circulation 1989; 79:I68.</a></li><li><a class="nounderline abstract_t">Curtis JJ, Walls JT, Salam NH, et al. Impact of unstable angina on operative mortality with coronary revascularization at varying time intervals after myocardial infarction. J Thorac Cardiovasc Surg 1991; 102:867.</a></li><li><a class="nounderline abstract_t">Tanaka N, Mukai K, Ade W, et al. Emergency myocardial revascularization for myocardial infarction evolving outside the hospital. A feasible option when thrombolysis and coronary angioplasty have failed. J Cardiovasc Surg (Torino) 1993; 34:215.</a></li><li><a class="nounderline abstract_t">Nicolau JC, Ardito RV, Garzon SA, et al. Surgical revascularization after fibrinolysis in acute myocardial infarction. Long-term follow-up. J Thorac Cardiovasc Surg 1994; 107:1454.</a></li><li><a class="nounderline abstract_t">Kaul TK, Fields BL, Riggins SL, et al. Coronary artery bypass grafting within 30 days of an acute myocardial infarction. Ann Thorac Surg 1995; 59:1169.</a></li><li><a class="nounderline abstract_t">Svensson LG, Cruz H, Sun J, et al. Timing of surgery after acute myocardial infarction. J Cardiovasc Surg (Torino) 1996; 37:467.</a></li><li><a class="nounderline abstract_t">Alexiou K, Kappert U, Staroske A, et al. Coronary surgery for acute coronary syndrome: which determinants of outcome remain? Clin Res Cardiol 2008; 97:601.</a></li><li><a class="nounderline abstract_t">Filizcan U, Kurc E, Cetemen S, et al. Mortality predictors in ST-elevated myocardial infarction patients undergoing coronary artery bypass grafting. Angiology 2011; 62:68.</a></li><li><a class="nounderline abstract_t">Authors/Task Force members, Windecker S, Kolh P, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35:2541.</a></li><li><a class="nounderline abstract_t">Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. J Am Coll Cardiol 2016; 67:1235.</a></li></ol></div><div id="topicVersionRevision">Topic 47 Version 32.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20730001" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Role of coronary artery bypass grafting during the acute and subacute phase of ST-elevation myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10831942" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Role of cardiac surgery in the hospital phase management of patients treated with primary angioplasty for acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28941611" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Quality of Acute Myocardial Infarction Care in Canada: A 10-Year Review of 30-Day In-Hospital Mortality and 30-Day Hospital Readmission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33931231" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Coronary artery bypass grafting after acute ST-elevation myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26152708" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Percutaneous Coronary Intervention at Centers With and Without On-Site Surgical Backup: An Updated Meta-Analysis of 23 Studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1815767" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Emergency coronary artery bypass surgery following failed balloon angioplasty: role of the internal mammary artery graft.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1616379" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Emergency coronary artery bypass surgery for failed percutaneous coronary angioplasty. A 10-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1934417" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Early and long-term outcome after emergency coronary artery bypass surgery after failed coronary angioplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2401061" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Failed elective percutaneous transluminal coronary angioplasty requiring coronary artery bypass surgery. In-hospital and late clinical outcome at 5 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17105759" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Coronary intervention for persistent occlusion after myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10618300" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20530505" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22064601" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22064598" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34882436" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30165437" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : 2018 ESC/EACTS Guidelines on myocardial revascularization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22064600" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7829793" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Coronary artery bypass graft surgery after thrombolytic therapy in the Thrombolysis in Myocardial Infarction Trial, Phase II (TIMI II).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18355509" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Early and late survival after surgical revascularization for ischemic ventricular fibrillation/tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1593036" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Influence of coronary bypass surgery on subsequent outcome of patients resuscitated from out of hospital cardiac arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11308159" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Optimal timing of revascularization: transmural versus nontransmural acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2785879" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Coronary artery bypass graft surgery early after acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7598589" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Revascularization after acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6601208" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Coronary bypass operation following acute complicated myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2526573" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Favorable early and long-term prognosis following coronary bypass surgery therapy for myocardial infarction: results of a multicenter trial. TAMI Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2203557" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Revascularization for acute myocardial infarction. Strategies in need of revision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3261648" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Coronary artery bypass for recent infarction. Predictors of mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1943193" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Coronary artery bypass grafting within thirty days of acute myocardial infarction. Early and late results in 406 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6334199" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Timing of coronary revascularization after acute myocardial infarction. Early and late results in patients revascularized within seven weeks.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8176975" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Surgical revascularization after acute myocardial infarction. Does timing make a difference?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9347842" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Risk analysis of coronary bypass surgery after acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17588374" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Predictors and outcomes of coronary artery bypass grafting in ST elevation myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29457560" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Prophylactic intra-aortic balloon counterpulsation before surgical myocardial revascularization in patients with acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22935569" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31794086" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The postoperative use of Impella as a ventricular assist device in high-risk patients undergoing coronary artery bypass surgery: A case series and comparison.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25861963" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31523850" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Timely extracorporeal membrane oxygenation assist reduces mortality after bypass surgery in patients with acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8487565" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Superiority of controlled surgical reperfusion versus percutaneous transluminal coronary angioplasty in acute coronary occlusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8487565" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Superiority of controlled surgical reperfusion versus percutaneous transluminal coronary angioplasty in acute coronary occlusion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10384184" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Coronary artery bypass without cardiopulmonary bypass for patients with acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19258083" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Off-pump versus on-pump myocardial revascularization in patients with ST-segment elevation myocardial infarction: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8590744" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Surgical treatment of acute myocardial infarct: clinical considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1804831" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Surgical treatment of acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1080822" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Acute myocardial infarction: a surgical emergency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2738273" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Medical and surgical management of early Q wave myocardial infarction. I. Effects of surgical reperfusion on survival, recurrent myocardial infarction, sudden death and functional class at 10 or more years of follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8901724" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Characteristics, management, and outcome of patients with acute myocardial infarction treated with bypass surgery. Myocardial Infarction Triage and Intervention Investigators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3499257" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Emergency coronary bypass for cardiogenic shock.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2811406" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Studies on prolonged acute regional ischemia. VI. Myocardial infarction with left ventricular power failure: a medical/surgical emergency requiring urgent revascularization with maximal protection of remote muscle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1080950" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Myocardial revascularization after acute infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/506940" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Medical and surgical management of myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6970859" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Immediate coronary artery bypass for acute evolving myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6972749" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Coronary bypass for relief of persistent pain following acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6333559" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Acute evolving myocardial infarction. A surgical emergency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4045035" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Early myocardial revascularization for postinfarction angina: results and long-term follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3947161" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Reperfusion protocol and results in 738 patients with evolving myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3497616" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Early myocardial revascularization for postinfarction angina.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2977054" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Immediate bypass surgery (0.5-3 h) for evolving myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3266428" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Surgical treatment of evolving and sustained myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3266429" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Emergency aortocoronary bypass surgery: late effects on infarct size and ventricular function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2977055" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Emergent surgical revascularization following acute myocardial infarction. Experimental and clinical considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3266431" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Emergency coronary artery reperfusion for acute evolving myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2785880" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : The risk of coronary bypass surgery for patients with postinfarction angina.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2785878" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Coronary artery bypass grafting for postinfarction angina pectoris.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1960990" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Impact of unstable angina on operative mortality with coronary revascularization at varying time intervals after myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8344971" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Emergency myocardial revascularization for myocardial infarction evolving outside the hospital. A feasible option when thrombolysis and coronary angioplasty have failed.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8196387" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Surgical revascularization after fibrinolysis in acute myocardial infarction. Long-term follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7733715" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Coronary artery bypass grafting within 30 days of an acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8941687" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Timing of surgery after acute myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18379855" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Coronary surgery for acute coronary syndrome: which determinants of outcome remain?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20462895" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Mortality predictors in ST-elevated myocardial infarction patients undergoing coronary artery bypass grafting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25173339" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26498666" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
